We have synthesized derivatives of dephostatin, a protein tyrosine phosphatase (PTPase) inhibitor, to study the structure-activity relationships of this inhibitor. Inactive analogs revealed someinsight into structural requirements for PTPase inhibitory activity of dephostatin. Both a nitroso group and phenolic hydroxyl groups were found to be essential for the inhibitory activity.
Amongthe dephostatin derivatives synthesized, one of the regioisomers of dephostatin showed
PTPase inhibitory activity equivalent to that of dephostatin, and also had increased stability.
Protein tyrosine phosphatase (PTPase) has been implicated in the regulation of the cell cycle and activation of lymphocytes1 '2) . A novel protein tyrosine phosphatase inhibitor, dephostatin 1, was isolated from the culture filtrate of Streptomyces sp. MJ742-NF5in our laboratory3'4).
In spite of its potential significance as a biochemical and therapeutic agent, sufficient amounts of dephostatin were difficult to obtain from the natural source. Therefore, we established a practical synthetic route for dephostatin5). However, dephostatin is not stable enough, and partial decomposition is frequently observed under storage and under conditions of biological experiments. Therefore, we synthesized several structurally related dephostatin analogs. As lability of dephostatin should arise from its hydroquinone or 7V-nitroso moiety, these structural elements were modified.
Results
Synthesis of Dephostatin Analogs Wesynthesized 13 dephostatin analogs as shownin Fig. 1 . Amongthem were some regioisomers of dephostatin (2, 3, and 4) . Then, to clarify the role of the two hydroxyl groups in PTPase inhibitory activity, we synthesized two monohydroxyl analogs (5 and 6) and two methyl ether analogs (7 and 8) of the inhibitor. A carboxyl derivative (9), in which both of the hydroxyl groups were replaced by carboxyl groups, was also examined. Additionally, amide and sulfonamide derivatives (10a to lOe), in place of nitrosamine, were tested to investigate whether the labile and potentially toxic nitroso moiety could be removed from the overall structure.
Attempts to synthesize 2, 3 and 4 by applying our synthetic route to dephostatin5) starting from corresponding dimethoxyanilines were not successful, therefore, modifications of reaction conditions and/or protecting groups were needed. Analogs 3 and 4 were synthesized in similar manners as the case of dephostatin (Scheme 2). Other derivatives, 5 and 6, 7, 9 and 10a~10e, were synthesized as shown in Schemes 3, 4, 5 and 6, respectively. Compound 8 was synthesized as already reported5). In scheme 3, the TBS group was removed without HFin the condition to eliminate the trifluoroacetyl group.
PTPase Inhibitory Activity of Dephostatin Analogs
PTPase inhibitory activities of the above analogs were examined by the method described previously3). The IC50 value of each analog is listed in Table 1 . Amongthem, only 2 has showed inhibitory activity equivalent to that of dephostatin.
Discussion
Since all the amide and sulfonamide analogs had no effect on the PTPase, the Af-nitroso moiety ofdephostatin must play a crucial role in PTPase inhibition. An equally important structural factor is the presence of two unmasked hydoxyl groups on the benzene ring. So far only 2,5-and 3,4-substitutions (dephostatin and 2, respectively) gave the inhibitory activity. Monohydroxyl and methoxy analogs had no inhibitory activity. Replacement of hydroxyl groups by carboxyl groups, which are similarly anionic, could not maintain the PTPase inhibitory activity. (1.78ml, 7.74mmol ) under argon at 0°C, and the solution was stirred at room temperature for 12 hours. The solution was poured into water and extracted with EtOAc twice. The organic layer was washed with saturated NaHCO3 and brine successively, then, dried over Na2SO4and concentrated to dryness. The resulting dark brown oil was purified by silica gel column chromatography with EtOAc-«-hexane (1 : 20 to 1 : 10) of K2CO3 (7% K2CO3-MeOH= 2 : 5). The solution was stirred at room temperature for 3 hours. Then, the reaction mixture was extracted with CH2C12 twice. The organic layer was dried over Na2SO4 and concentrated in vacuo. The residue was purified by elution from a silica gel column with EtOAc-rc-hexane (1:15 to 1:10) to give 142mg of16 (0.387mmol, 74% DEC. 1995 yield) as colorless needles: mp 34~35°C. IR (KBr) vmax 3428, 2857, 1617, 1514, 1275, 1251, 840cm-1 3, 144.2, 138.6, 121.5, 106.0, 105.5, 31.4, 26.0, 26.0, 18.5, 18.4, -4 3 ,4-Dihydroxy-TV-methyl-A^-nitrosoaniline (2) To a solution of 17 (58.3mg, 0.147mmol) in 6ml of THF was added 1.5ml of NaF-HF buffer (pH 4.98, prepared as reported7)) under argon at 0°C. The solution was stirred at room temperature for 24 hours. The reaction mixture was extracted with CHC13three times. The organic layer was dried over Na2SO4and concentrated in vacuo. The residue was purified on preparative 
